Tarek Hashem
Overview
Explore the profile of Tarek Hashem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkholy E, Abdou A, Alhanafy A, Hashem T, Hassan R, Shehata M
Indian J Cancer
. 2024 Jan;
61(1):51-60.
PMID: 38216547
Background: Serine-Arginine (SR) proteins are a conserved family of proteins involved in RNA splicing and are reported to be over-expressed in multiple cancers. The aim of the study is evaluation...
2.
Aboelhassan R, Sobeih M, El-Din M, Ghali R, El-Din I, Khorshid O, et al.
Ther Adv Med Oncol
. 2023 Nov;
15:17588359231212182.
PMID: 38028146
Background: Stage III non-small cell lung cancer (NSCLC) being highly heterogeneous requires multimodal therapeutic strategies for optimal management. We present findings on treatment patterns and their associated survival outcomes in...
3.
Hashem T, Taha S, Orabi A
Indian J Surg Oncol
. 2023 Mar;
14(1):181-185.
PMID: 36891444
Perforator flaps are the latest development in reconstructive surgery. Pedicled chest wall perforator flaps can be utilized in many cases of partial breast reconstruction. This research compares the outcome and...
4.
Abdulla M, Belal A, Sakr A, El Arab L, Mokhtar M, Allahloubi N, et al.
Health Sci Rep
. 2023 Jan;
6(1):e1037.
PMID: 36698712
Introduction: The use of cisplatin in clinical practice in the management of head and neck squamous cell carcinoma (HNSCC) is limited by its toxicity and acquired resistance, which makes the...
5.
Orabi A, Youssef M, Manie T, Shaalan M, Hashem T
J Egypt Natl Canc Inst
. 2022 Jan;
34(1):2.
PMID: 35001182
Background: Breast conserving surgery (BCS) has been a standard procedure for the treatment of breast cancer instead of mastectomy whenever possible. Lateral chest wall perforator flaps are one of the...
6.
Erman M, Biswas B, Danchaivijitr P, Chen L, Wong Y, Hashem T, et al.
BMC Cancer
. 2021 Nov;
21(1):1191.
PMID: 34753434
No abstract available.
7.
Erman M, Biswas B, Danchaivijitr P, Chen L, Wong Y, Hashem T, et al.
BMC Cancer
. 2021 Sep;
21(1):1021.
PMID: 34521387
Background: Clinical effectiveness and safety data of pazopanib in patients with advanced or mRCC in real-world setting from Asia Pacific, North Africa, and Middle East countries are lacking. Methods: PARACHUTE...
8.
Metwally S, Abo-Shadi M, Abdel Fattah N, Barakat A, Rabee O, Osman A, et al.
Infect Drug Resist
. 2021 Jun;
14:2327-2339.
PMID: 34188499
Background: Oncogenic viruses, their possible association with breast cancer (BC) and effect on its clinical course are interesting issue. The present study evaluates the presence of human papillomavirus (HPV), EpsteinBarr...
9.
Hashem T, Abdelmoez A, Rozeka A, Abdelazeem H
World J Surg Oncol
. 2021 Apr;
19(1):114.
PMID: 33849561
Background: Due to the high variability of incidence and prevalence of intra-mammary lymph nodes (IMLNs), they might be overlooked during clinical and radiological examinations. Properly characterizing pathological IMLNs and detecting...
10.
Boutrus R, El Sherif S, Abdelazim Y, Bayomy M, Gaber A, Farahat A, et al.
Int J Radiat Oncol Biol Phys
. 2021 Mar;
109(5):1296-1300.
PMID: 33714527
Purpose: The aim of the current study was to compare toxicity, cosmesis, and local control between the once daily and the twice daily fractionation schemes for external beam accelerated partial...